Resectoscope Devices Market – By Type, By Application, By End Use – Global Forecast, 2025 to 2034

Resectoscope Devices Market Size

The global resectoscope devices market size was valued at USD 402.2 million in 2024 and is expected to exhibit growth at a CAGR of 5.7% from 2025 to 2034 period, owing to the increasing incidence of urological and gynecological disorders and the preference for less invasive procedures.
 

The demand for transurethral resection procedures is increasing around the world along with the prevalence of bladder cancer and benign prostatic hyperplasia (BPH). For instance according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), it is estimated that BPH affects about 50% of men in the age range of 51 to 60, thus boosting the need for such treatments. These advanced surgeries are known as minimally invasive surgeries which utilize advanced instruments like resectoscopes for faster recovery and greater accuracy when compared to traditional surgeries.

Resectoscopes are employed in urology and gynecology where they allow surgeons to perform surgeries with minimum incisions or cuts. They incorporate a source of illumination, an irrigation device, and an electrical unit for the accurate cutting away of tissues in a bladder, prostate or uterus.
 

Resectoscope Devices Market Trends

• The increase in market demand is driven by the change in technology which leads to improvements in operational effectiveness, safety, and exactness of surgical procedures. This drives the use of resectoscope devices in different medical fields, especially in gynecology and urology.
   
• New resectoscope equipment has been developed with camera systems and optics that allow for greater visualization for the surgeon during operations. This will improve accuracy and eliminate the chances of complications with the procedure, in particular fragile procedures like transurethral resection of the prostate, or TURP.
   
• Additionally, the innovations of the energy-based technologies such as the bipolar and laser systems are being incorporated into the resectoscope devices. These systems enable more effective cutting, coagulating, and ablating of tissues, which allows more minimally invasive procedures that have quicker recoveries and less discomfort to the patient.
   
• Furthermore, these enhanced insulation of the instruments as well as the controlled energy will reduce the chances of unwanted tissue damage and other injuries. These features are very important for patient safety and surgical effectiveness.
   

Resectoscope Devices Market Analysis

 Based on type, the market is segmented as monopolar resectoscopes, bipolar resectoscopes, and hybrid resectoscopes. The monopolar resectoscopes segment is expected to drive business growth and expand at a CAGR of 5.5%, reaching over USD 327.3 million by 2034
 

• Monopolar resectoscopes are used most frequently for the transurethral resection of the prostate (TURP) and various bladder surgeries. In gynecology, they are also preferred for effective treatment of hysteroscopic surgeries.
   
• Additionally, among the bipolar systems, monopolar resectoscopes are, in most cases, cheaper and are thereby the favored option by medical centers that don't have deep pockets. This low price ensures that it is broadly embraced both in developed markets and the ones that are emerging.
   

Based on application, the resectoscope devices market is segmented as urology, gynecology, general surgery, and other applications. The urology segment is expected to drive business growth and expand at a CAGR of 5.8%, reaching over USD 294.6 million by 2034.
 

• An increasing geriatric population has led to more cases of urological disorders including bladder cancer and enlargement of the prostate. Such conditions often require their surgical treatments where resectoscopes are extremely important, thereby escalating the demand for this kind of surgical device.
   
• Urology has been the first among other medical disciplines to use less invasive measures such as the transurethral resection of the prostate (TURP) and resection of the bladder tumor. The use of specialized resectoscopes in these surgical procedures is in high demand due to their comparative advantage in developed healthcare markets.

Based on end use, the resectoscope devices market is classified into hospitals, clinics, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 45.6% in 2024.
 

• The hospitals segment is equipped with modern operating theaters and advanced imaging systems making the use of resectoscope devices most efficient. Their incorporation into complex surgical workflows is what continues to secure their place at the top of the field.
   
• The fact that there are urologists, gynecologists, and other specialists trained to use resectoscope devices accurately makes it safer to perform the procedures. This is the reason why complex and minimally invasive surgeries are done in hospitals.

The U.S. resectoscope devices market accounted for USD 148.7 million in 2024 and is anticipated to grow at a CAGR of 4.9% between 2025 to 2034 period.
 

• The availability, coupled with a large number of these market players providing innovative resectoscope solutions, is driving the U.S. market.
   
• Additionally, high spending on healthcare, an increasing number of elderly people, and a high rate of minimally invasive surgeries make a big contribution to why the country is in this position.
   

France resectoscope devices market is projected to grow remarkably in the coming years.
 

• The advancement of technology in surgery and the increase in BPH cases among the older demographic have resulted in a surging demand for resectoscope devices.
   
• Additionally, the greater market share of the nation is also due to France concentrating on improving surgical results through training and investing in healthcare innovation.
   

China holds a dominant position in the Asia Pacific resectoscope devices market.
 

• In addition to government modernization of healthcare facilities, the growing range of urology and gynecology disorders has increased the demand for resectoscope devices.
   
• China is quickly emerging as a lucrative market with a lot of unrealized potential because of the rising adoption of minimally invasive surgical methods and a rapidly growing pool of qualified healthcare workers.
   

Resectoscope Devices Market Share

Several key players in the market are working on product development and contemplating alliances in order to have a competitive edge. Significant investments in R&D to create more sophisticated resectoscope devices that have better visualization, more ergonomic designs, and are safer for the user is ongoing in the companies. Moreover, collaborations with other healthcare institutions are being developed to increase availability in the less developed markets. Compliance with existing regulations and meeting the anticipated international standards is another factor these companies consider when developing strategies for the global market.
 

USPs of the Resectoscope Devices Market

• Market players ensure precise and efficient resections through innovative designs.
   
• Focused on offering high-quality materials for safe and effective surgical procedures.
   
• Companies undertake R&D activities to provide a comprehensive range of devices for various urological and gynecological applications.
   
• Market players deliver superior outcomes with expertise trusted by healthcare professionals worldwide.
   

Resectoscope Devices Market Companies

Prominent players operating in the resectoscope devices industry include:

• Advin Urology
• bissinger
• ESC Medicams
• ENDOMED SYSTEMS
• JDmeditech
• KARL STORZ
• LEPU MEDICAL
• OLYMPUS
• Orion Medical
• Richard Wolf
• Stryker
• TONTARRA
   

Resectoscope Devices Industry News:

• In November 2024, Olympus Corporation of the Americas showcased a comprehensive range of gynecological solutions at the American Association of Gynecological Laparoscopists (AAGL) World Congress in New Orleans. Some of the major developments included the VERSAPOINT II Bipolar Electrosurgery System and 8.5 MM Hystero-resectoscope which offered advanced plasma hysteroscope resection. These developments increased the level of precision and safety in gynecological procedures and sought to answer a growing demand for minimally invasive surgical procedures.
   

The resectoscope devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Monopolar resectoscopes
• Bipolar resectoscopes
• Hybrid resectoscopes

Market, By Application

• Urology
• Gynecology
• General surgery
• Other applications

Market, By End Use

• Hospitals
• Clinics
• Ambulatory surgical centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE